Julie K. Jadlowsky, Ph.D.
Affiliations: | 2008 | Case Western Reserve University, Cleveland Heights, OH, United States |
Area:
Molecular BiologyGoogle:
"Julie Jadlowsky"Parents
Sign in to add mentor| Jonathan Karn | grad student | 2008 | Case Western | |
| (Dual control of HIV transcription elongation: Virus-specific negative control by NELF-E is counterbalanced by positive transcription factor P -TEFb.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou Y, Jadlowsky J, Baiduc C, et al. (2023) Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. Plos Pathogens. 19: e1011853 |
| Jung IY, Noguera-Ortega E, Bartoszek R, et al. (2023) Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors. Cell Reports. Medicine. 101053 |
| Jung IY, Narayan V, McDonald S, et al. (2022) BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion. Science Translational Medicine. 14: eabn7336 |
| Kong W, Dimitri A, Wang W, et al. (2021) BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia. The Journal of Clinical Investigation. 131 |
| Zhou Y, Maldini CR, Jadlowsky J, et al. (2021) Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy. The Journal of Infectious Diseases. 223: 38-45 |
| Tebas P, Jadlowsky JK, Shaw PA, et al. (2021) CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication. The Journal of Clinical Investigation |
| Jacobson JM, Jadlowsky JK, Lacey SF, et al. (2020) Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Lundh S, Jung IY, Dimitri A, et al. (2020) Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancer. Clinical and Experimental Medicine |
| Stadtmauer EA, Fraietta JA, Davis MM, et al. (2020) CRISPR-engineered T cells in patients with refractory cancer. Science (New York, N.Y.) |
| Xu J, Gohil M, Stadtmauer E, et al. (2020) Characterization of autologous T cells engineered to express NY-ESO-1 TCR with multiplexed CRISPR/Cas9 editing (NYCE T Cells) Cytotherapy. 22: S35-S36 |